Advanced Point-Of-Care Liver Health Assessment
Hepatoscope is a breakthrough non-invasive point-of-care solution for early assessment of chronic liver disease.
Easy to use, ultra-portable, and accessible to any healthcare professional, it facilitates mass triage of patients at risk of developing liver steatosis and fibrosis.
40% of patients living with Type 2 Diabetes and obesity have advanced liver fibrosis*
How can you assess your patients?
Hepatoscope measures liver stiffness (LSM) and three steatosis-related parameters. Measurements are performed under image guidance to ensure the confidence needed for proper patient care.
Ready to integrate liver assessment in your clinical practice?
Hepatoscope is designed with ease of use in mind, allowing any healthcare professional to perform a liver exam in less than 4 minutes.
*High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold, Castera et al. 2023
Financial Flexibility
E-Scopics proposes flexible options to acquire Hepatoscope, either via Membership (pay-as-you-go) or Ownership (capital purchase), to adapt to your practice and requirements.
Contact us to understand how we can support you in developing an efficient management plan for your patients at risk of liver disease.
Clinically validated Trusted by healthcare teams globally
Validated in Hepatology, GI and Endocrinology practices in line with the latest clinical practice guidelines
Demonstrated repeatability and reproducibility of measurements
BMI-independent measurements
Hepatoscope helps clinicians manage patients confidently
